Cathy Yunjia Zhao (Cathy Zhao, Cathy Y Zhao)

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Topics

Epidermal Growth Factor Receptor

Top Venues

The Australasian journal of dermatology

Pigment cell & melanoma research

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas E Pennington, Cathy Yunjia Zhao, Andrew J Colebatch, Pablo Fernandez-Peñas, Pascale Guitera, Hazel Burke, Richard A Scolyer, Alexander M Menzies, Matteo S Carlino, Serigne Lo, Georgina V Long, Robyn Pm Saw
Clinicopathological characteristics of new primary melanomas in patients receiving immune checkpoint inhibitor therapy for metastatic melanoma. The Australasian journal of dermatology 63 (2) (2022)
Kevin W Jiang, Cathy Yunjia Zhao, Charles Chan, Monica Y Peduto, Gajan Kailainathan, David K Cook
Eruptive Bowen's Disease in a patient on pembrolizumab for Hodgkin's lymphoma. The Australasian journal of dermatology 62 (3) (2021)
Ashod Kherlopian, Cathy Yunjia Zhao, Ludi Ge, Emily Forward, Gayle Fischer
A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination. The Australasian journal of dermatology (2021)
Samantha Ting, Samuel S Zagarella, Cathy Yunjia Zhao, Brook Lee, Charles Chan
Vesiculobullous Hailey-Hailey's disease with scarring mimicking a subepidermal autoimmune blistering disease and its management with retinoids. The Australasian journal of dermatology 62 (3) (2021)
Cathy Yunjia Zhao, Pablo Fernandez-Penas
Is it worthy to treat hidradenitis suppurativa with adalimumab in patients with melanoma and other debilitating systemic diseases? A series of clinical dilemmas. The Australasian journal of dermatology 59 (4) (2018)
Cathy Yunjia Zhao, Shaun Chou, Rose Congwei Liu, Pablo Fernandez-Peñas
Naevus lightening in melanoma patients under BRAF/MEK inhibitor combination therapy versus checkpoint immunotherapy: A histological and immunohistochemistry analysis. Pigment cell & melanoma research 31 (2) (2017)
Cathy Yunjia Zhao, Rose C Liu, Germana Consuegra, Rina Hui, Pablo Fernandez-Penas
Epidermal growth factor receptor inhibitor-induced papulopustular eruption successfully treated with low-dose oral dapsone. The Australasian journal of dermatology 59 (3) (2017)